STOCK TITAN

[SCHEDULE 13G] Verastem, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Schedule 13G filing shows investment adviser Logos Global Management LP and affiliates (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC and Dr. Arsani William) have accumulated 3,425,000 Verastem (VSTM) common shares, equal to 6.2 % of the 54.95 million shares outstanding as reported on 12 May 2025.

The position is held through Logos Global Master Fund LP. All reporting persons report 0 sole voting/dispositive power and shared voting & dispositive power over the full stake. The stake was acquired in the ordinary course of business; the use of Schedule 13G indicates a passive investment with no intent to influence control. Event date triggering the filing is 21 Jul 2025, and certifications confirm no control-seeking purpose. Each party disclaims group status and beneficial ownership beyond its pecuniary interest.

Il deposito Schedule 13G mostra che il consulente di investimento Logos Global Management LP e le affiliate (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC e il Dr. Arsani William) hanno accumulato 3.425.000 azioni ordinarie di Verastem (VSTM), pari al 6,2% delle 54,95 milioni di azioni in circolazione come riportato il 12 maggio 2025.

La posizione è detenuta tramite Logos Global Master Fund LP. Tutte le persone che riportano dichiarano di avere 0 potere di voto/dispositivo esclusivo e potere di voto e dispositivo condiviso sull'intera partecipazione. La quota è stata acquisita nell'ordinaria attività commerciale; l'uso del Schedule 13G indica un investimento passivo senza intenzione di influenzare il controllo. La data dell'evento che ha determinato il deposito è il 21 luglio 2025, e le certificazioni confermano l'assenza di finalità di controllo. Ogni parte nega lo status di gruppo e la titolarità effettiva oltre il proprio interesse pecuniario.

La presentación del Schedule 13G muestra que el asesor de inversiones Logos Global Management LP y sus afiliados (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC y el Dr. Arsani William) han acumulado 3,425,000 acciones comunes de Verastem (VSTM), equivalentes al 6.2 % de las 54.95 millones de acciones en circulación según lo reportado el 12 de mayo de 2025.

La posición se mantiene a través de Logos Global Master Fund LP. Todas las personas que reportan indican tener 0 poder exclusivo de voto/disposición y poder compartido de voto y disposición sobre toda la participación. La participación fue adquirida en el curso ordinario de negocios; el uso del Schedule 13G indica una inversión pasiva sin intención de influir en el control. La fecha del evento que desencadenó la presentación es el 21 de julio de 2025, y las certificaciones confirman que no hay propósito de buscar control. Cada parte niega el estatus de grupo y la propiedad beneficiaria más allá de su interés pecuniario.

Schedule 13G 제출서에 따르면 투자 자문사 Logos Global Management LP와 그 계열사들(로고스 글로벌 매니지먼트 GP LLC, 로고스 글로벌 마스터 펀드 LP, 로고스 GP LLC, 그리고 Dr. Arsani William)이 Verastem (VSTM) 보통주 3,425,000주를 보유하고 있으며, 이는 2025년 5월 12일 기준 발행 주식 5,495만 주의 6.2%에 해당합니다.

이 지분은 Logos Global Master Fund LP를 통해 보유하고 있습니다. 모든 보고자는 단독 의결권/처분권은 0이며 전체 지분에 대해 공동 의결권 및 처분권을 보유하고 있다고 보고합니다. 이 지분은 정상적인 사업 과정에서 취득되었으며, Schedule 13G 사용은 통제권 행사 의도가 없는 수동적 투자임을 나타냅니다. 제출을 촉발한 사건일은 2025년 7월 21일이며, 인증서들은 통제권 추구 목적이 없음을 확인합니다. 각 당사자는 그룹 지위 및 경제적 이익을 초과하는 실질 소유권을 부인합니다.

Le dépôt du Schedule 13G révèle que le conseiller en investissement Logos Global Management LP et ses affiliés (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC et le Dr Arsani William) ont accumulé 3 425 000 actions ordinaires de Verastem (VSTM), représentant 6,2 % des 54,95 millions d’actions en circulation selon le rapport du 12 mai 2025.

La position est détenue via Logos Global Master Fund LP. Toutes les personnes déclarantes indiquent détenir 0 pouvoir exclusif de vote/disposition et un pouvoir partagé de vote et de disposition sur l’intégralité de la participation. La participation a été acquise dans le cours normal des affaires ; l’utilisation du Schedule 13G indique un investissement passif sans intention d’influencer le contrôle. La date de l’événement déclencheur du dépôt est le 21 juillet 2025, et les certifications confirment l’absence de volonté de prise de contrôle. Chaque partie nie le statut de groupe et la propriété bénéficiaire au-delà de son intérêt pécuniaire.

Die Einreichung des Schedule 13G zeigt, dass der Investmentberater Logos Global Management LP und verbundene Unternehmen (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC und Dr. Arsani William) 3.425.000 Stammaktien von Verastem (VSTM) angesammelt haben, was 6,2 % der 54,95 Millionen ausstehenden Aktien entspricht, wie am 12. Mai 2025 berichtet wurde.

Die Position wird über Logos Global Master Fund LP gehalten. Alle berichtenden Personen geben an, 0 alleiniges Stimm- und Verfügungsrecht und gemeinsames Stimm- und Verfügungsrecht über den gesamten Anteil zu besitzen. Die Beteiligung wurde im normalen Geschäftsverlauf erworben; die Verwendung des Schedule 13G weist auf eine passive Investition ohne Kontrollabsicht hin. Das Ereignisdatum, das die Einreichung auslöste, ist der 21. Juli 2025, und Zertifizierungen bestätigen, dass kein Kontrollzweck verfolgt wird. Jede Partei lehnt den Status einer Gruppe und wirtschaftliches Eigentum über ihr finanzielles Interesse hinaus ab.

Positive
  • Institutional investor Logos Global Management disclosed a 6.2 % passive ownership in Verastem, signalling increased professional interest and potential support for the stock.
Negative
  • None.

Insights

TL;DR: 6.2 % passive stake disclosed; modestly positive signal of institutional interest, limited governance impact.

The filing confirms that Logos Global, an institutional investor, now owns more than the 5 % threshold, requiring disclosure. Because the stake is filed on Schedule 13G, it is deemed passive, implying no activist agenda or imminent governance pressure on Verastem. The size—3.43 M shares—makes Logos a top-10 holder and may improve liquidity and market perception, but it does not alter control dynamics (shared voting only). Overall market impact should be modestly constructive, highlighting external confidence while posing minimal strategic risk.

Il deposito Schedule 13G mostra che il consulente di investimento Logos Global Management LP e le affiliate (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC e il Dr. Arsani William) hanno accumulato 3.425.000 azioni ordinarie di Verastem (VSTM), pari al 6,2% delle 54,95 milioni di azioni in circolazione come riportato il 12 maggio 2025.

La posizione è detenuta tramite Logos Global Master Fund LP. Tutte le persone che riportano dichiarano di avere 0 potere di voto/dispositivo esclusivo e potere di voto e dispositivo condiviso sull'intera partecipazione. La quota è stata acquisita nell'ordinaria attività commerciale; l'uso del Schedule 13G indica un investimento passivo senza intenzione di influenzare il controllo. La data dell'evento che ha determinato il deposito è il 21 luglio 2025, e le certificazioni confermano l'assenza di finalità di controllo. Ogni parte nega lo status di gruppo e la titolarità effettiva oltre il proprio interesse pecuniario.

La presentación del Schedule 13G muestra que el asesor de inversiones Logos Global Management LP y sus afiliados (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC y el Dr. Arsani William) han acumulado 3,425,000 acciones comunes de Verastem (VSTM), equivalentes al 6.2 % de las 54.95 millones de acciones en circulación según lo reportado el 12 de mayo de 2025.

La posición se mantiene a través de Logos Global Master Fund LP. Todas las personas que reportan indican tener 0 poder exclusivo de voto/disposición y poder compartido de voto y disposición sobre toda la participación. La participación fue adquirida en el curso ordinario de negocios; el uso del Schedule 13G indica una inversión pasiva sin intención de influir en el control. La fecha del evento que desencadenó la presentación es el 21 de julio de 2025, y las certificaciones confirman que no hay propósito de buscar control. Cada parte niega el estatus de grupo y la propiedad beneficiaria más allá de su interés pecuniario.

Schedule 13G 제출서에 따르면 투자 자문사 Logos Global Management LP와 그 계열사들(로고스 글로벌 매니지먼트 GP LLC, 로고스 글로벌 마스터 펀드 LP, 로고스 GP LLC, 그리고 Dr. Arsani William)이 Verastem (VSTM) 보통주 3,425,000주를 보유하고 있으며, 이는 2025년 5월 12일 기준 발행 주식 5,495만 주의 6.2%에 해당합니다.

이 지분은 Logos Global Master Fund LP를 통해 보유하고 있습니다. 모든 보고자는 단독 의결권/처분권은 0이며 전체 지분에 대해 공동 의결권 및 처분권을 보유하고 있다고 보고합니다. 이 지분은 정상적인 사업 과정에서 취득되었으며, Schedule 13G 사용은 통제권 행사 의도가 없는 수동적 투자임을 나타냅니다. 제출을 촉발한 사건일은 2025년 7월 21일이며, 인증서들은 통제권 추구 목적이 없음을 확인합니다. 각 당사자는 그룹 지위 및 경제적 이익을 초과하는 실질 소유권을 부인합니다.

Le dépôt du Schedule 13G révèle que le conseiller en investissement Logos Global Management LP et ses affiliés (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC et le Dr Arsani William) ont accumulé 3 425 000 actions ordinaires de Verastem (VSTM), représentant 6,2 % des 54,95 millions d’actions en circulation selon le rapport du 12 mai 2025.

La position est détenue via Logos Global Master Fund LP. Toutes les personnes déclarantes indiquent détenir 0 pouvoir exclusif de vote/disposition et un pouvoir partagé de vote et de disposition sur l’intégralité de la participation. La participation a été acquise dans le cours normal des affaires ; l’utilisation du Schedule 13G indique un investissement passif sans intention d’influencer le contrôle. La date de l’événement déclencheur du dépôt est le 21 juillet 2025, et les certifications confirment l’absence de volonté de prise de contrôle. Chaque partie nie le statut de groupe et la propriété bénéficiaire au-delà de son intérêt pécuniaire.

Die Einreichung des Schedule 13G zeigt, dass der Investmentberater Logos Global Management LP und verbundene Unternehmen (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC und Dr. Arsani William) 3.425.000 Stammaktien von Verastem (VSTM) angesammelt haben, was 6,2 % der 54,95 Millionen ausstehenden Aktien entspricht, wie am 12. Mai 2025 berichtet wurde.

Die Position wird über Logos Global Master Fund LP gehalten. Alle berichtenden Personen geben an, 0 alleiniges Stimm- und Verfügungsrecht und gemeinsames Stimm- und Verfügungsrecht über den gesamten Anteil zu besitzen. Die Beteiligung wurde im normalen Geschäftsverlauf erworben; die Verwendung des Schedule 13G weist auf eine passive Investition ohne Kontrollabsicht hin. Das Ereignisdatum, das die Einreichung auslöste, ist der 21. Juli 2025, und Zertifizierungen bestätigen, dass kein Kontrollzweck verfolgt wird. Jede Partei lehnt den Status einer Gruppe und wirtschaftliches Eigentum über ihr finanzielles Interesse hinaus ab.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G



Logos Global Management LP
Signature:/s/ Arsani William
Name/Title:Managing Partner
Date:07/28/2025
Logos Global Management GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:07/28/2025
Logos Global Master Fund LP
Signature:/s/ Arsani William
Name/Title:Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP
Date:07/28/2025
Logos GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:07/28/2025
Arsani William
Signature:/s/ Arsani William
Name/Title:Reporting person
Date:07/28/2025

FAQ

Who filed the Schedule 13G for Verastem (VSTM)?

Logos Global Management LP and related entities, including Logos Global Master Fund LP and Dr. Arsani William.

How many Verastem shares does Logos Global own?

The group reports 3,425,000 common shares.

What percentage of Verastem's outstanding stock is represented?

The holding equals 6.2 % of shares outstanding as of 12 May 2025.

Is the stake passive or activist?

Filed on Schedule 13G, the position is classified as passive with no intent to influence control.

Does Logos Global have sole voting power over the shares?

No. It reports 0 sole voting/dispositive power and shared power over all 3.43 M shares.

What event date triggered the filing requirement?

The relevant event date is 21 July 2025 when ownership exceeded 5 %.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

342.33M
49.81M
1.17%
76.29%
13.4%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM